Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Each has different success rates, timelines, and costs
The proposed mechanisms include reduced inflammation in the brain and improved blood flow
Wegovy (semaglutide 2.4 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or obstructive sleep apnoea
It is a prescription therapy, so safety depends on evaluation, correct dosing, pharmacy grade product, and monitoring
If you have cardiovascular disease, diabetes, sleep apnea, or other eligible diagnosis, ask whether GLP-1 might be appropriate for that indication
US$ 28.98
US$ 25.01
US$ 25.74
US$ 26.26
US$ 23.94
US$ 20.91
